These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83. Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335 [TBL] [Abstract][Full Text] [Related]
7. Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial. DeToledo JC; Ramsay RE; Lowe MR; Greiner M; Garofalo EA Ther Drug Monit; 2000 Dec; 22(6):753-6. PubMed ID: 11128246 [TBL] [Abstract][Full Text] [Related]
8. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89. Bergey GK; Morris HH; Rosenfeld W; Blume WT; Penovich PE; Morrell MJ; Leiderman DB; Crockatt JG; LaMoreaux L; Garofalo E; Pierce M Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334 [TBL] [Abstract][Full Text] [Related]
9. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures]. Pierce MW; Shokry A Praxis (Bern 1994); 1997 Sep; 86(37):1430-1. PubMed ID: 9381042 [TBL] [Abstract][Full Text] [Related]
10. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group. Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258 [TBL] [Abstract][Full Text] [Related]
12. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830 [TBL] [Abstract][Full Text] [Related]
13. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group. Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of gabapentin. Ramsay RE Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537 [TBL] [Abstract][Full Text] [Related]
16. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405 [TBL] [Abstract][Full Text] [Related]
18. Rapid initiation of gabapentin: a randomized, controlled trial. Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308 [TBL] [Abstract][Full Text] [Related]
19. Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5. Neurology; 1993 Nov; 43(11):2292-8. PubMed ID: 8232945 [TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study. Baulac M; Patten A; Giorgi L Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]